CompletedPhase 4ACTRN12608000414314

Topical alkane vapocoolant spray versus subcutaneous lignocaine injection for reducing the pain of intravenous cannulation: a randomised, controlled, clinical trial

A randomised clinical trial to compare the efficacy of pressurised vapocoolant spray and subcutaneous lignocaine injection in decreasing the pain of intravenous cannulation in the emergency department

Sponsor

Austin Health

Enrollment

220 participants

Start Date

Oct 1, 2008

Study Type

Interventional

Conditions

Pain of intravenous cannulation

Summary

Our previous research indicates vapocoolant is effective in significantly decreasing the pain of intravenous cannulation. This new study will compare vapocoolant with subcutaneous lignocaine, another common means of reducing the pain of cannulation.

Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 100 Yearss

Plain Language Summary

Simplified for easier understanding

This study compares two methods of reducing pain before inserting an IV needle — a cooling spray applied to the skin versus a small numbing injection (lignocaine). Researchers want to know which method is more effective and preferred by patients. It is for adults aged 18 and older who need an IV line placed in the emergency department.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Two second spray of pressurised vapocoolant 'Cold Spray' (butane, propane and pentane blend), from 12 cm, to the cannulation site. The alkane blend may vary with the batch and specific proportions of

Two second spray of pressurised vapocoolant 'Cold Spray' (butane, propane and pentane blend), from 12 cm, to the cannulation site. The alkane blend may vary with the batch and specific proportions of the three alkanes are not available.

Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12608000414314